Skip to content
On January 24, 2014, President Kaler issued a memorandum charging Vice President Brian Herman with responsibility for conducting an inquiry “examining policies, practices and oversight of clinical research on human subjects at the University, in particular clinical research involving adult participants with diminished functional abilities.” Kaler wrote, “The intent of this review is to ensure that the University’s processes for clinical research on human subjects meet or surpass the established best practices and norms and to instill confidence among faculty and the public that the University of Minnesota research is beyond reproach. It is to be a forward-looking, productive, and independent review of current practice by an external expert panel.” Kaler added, “I look forward to receiving the report of the independent panel and am confident that the results will demonstrate that our faculty, policies and practices meet the highest quality standards.”
On February 13, 2014, a “Request for Proposals” was posted to the “MBID system” on the University of Minnesota’s Purchasing Services website. The MBID system is used by the university to solicit bids for such goods and services as agricultural pesticide products, commercial fertilizer products, sandwiches, moving and hauling, toxic gas monitoring systems, and wood chip dryers. “Suppliers” must register on the MBID system to submit responses to “RFPs.”
Eric W. Kaler, “Re: Human Subject Research Review,” Memorandum from University of Minnesota President Kaler to Vice President for Research Brian Herman, January 24, 2014.